New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
15:30 EDTJNJJohnson & Johnson volatility flat into Q2 and growth outlook
Johnson & Johnson July call option implied volatility is at 14, August is at 13, October is at 12; compared to its 26-week average of 13 according to Track Data, suggesting non-directional price movement into the expected release of Q2 results on July 15.
News For JNJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
14:29 EDTJNJFDA grants Genmab priority review for daratumumab
Subscribe for More Information
08:20 EDTJNJBass slams PTO for blocking patent challenge, Business Insider reports
Subscribe for More Information
September 2, 2015
11:39 EDTJNJBass denied request for review of Biogen multiple sclerosis drug patent
Subscribe for More Information
August 27, 2015
19:49 EDTJNJJohnson & Johnson to open shared services headquarters in Florida
Subscribe for More Information
August 25, 2015
13:01 EDTJNJJ&J unit to sell Splenda brand to Heartland Food, terms not disclosed
Subscribe for More Information
09:03 EDTJNJAcorda has major overhang removed by IPR denials, says Leerink
Subscribe for More Information
06:18 EDTJNJSears names Lynn Pendergrass as Hardlines president
Subscribe for More Information
August 21, 2015
09:01 EDTJNJLeerink medical devices analyst holds an analyst/industry conference call
Medical Device Analyst Newitter, along with MEDACorp Specialists Dorance Dillon and Terence Farrell, discuss the Centers for Medicare & Medicaid Services' recently proposed "Comprehensive Care For Joint Replacement Payment Model" and how this model might influence ortho pricing and hospital-vendor relationships on an Analyst/Industry conference call to be held on August 24 at 1 pm.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use